Ampio Pharmaceuticals Inc (AMPE) stock has gained 47.62% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives AMPE stock a score of 71 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 87. In addition to the average rating from Wall Street analysts, AMPE stock has a mean target price of 4. This means analysts expect the stock to add 545.16% over the next 12 months. AMPE's rank also includes a long-term technical score of 65. The short-term technical score for AMPE is 61.
What's Happening with AMPE Stock Today
Ampio Pharmaceuticals Inc (AMPE) stock is down -6.52% while the S&P 500 has gained 0.59% as of 2:54 PM on Tuesday, Jun 30. AMPE is down -$0.04 from the previous closing price of $0.66 on volume of 2,409,589 shares. Over the past year the S&P 500 has risen 3.60% while AMPE has gained 47.62%. AMPE lost -$0.09 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Ampio Pharmaceuticals Inc (AMPE) Stock.
